Results 1 to 10 of about 92,575 (120)

Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters

BMC Psychiatry, 2023
Background Anabolic-androgenic steroid (AAS) dependence has numerous adverse health consequences, and may be driven in part by body image concerns, primarily muscle dysmorphia. This study aims to further understand and identify potential clinical targets
Morgan Scarth, Lars T. Westlye, Ingrid A. Havnes, Astrid Bjørnebekk   +3 more
doaj   +1 more source

Follistatin Protein Enhances Satellite Cell Counts in Reinnervated Muscle

Journal of Brachial Plexus and Peripheral Nerve Injury, 2022
Background Muscle recovery following peripheral nerve repair is sup-optimal. Follistatin (FST), a potent muscle stimulant, enhances muscle size and satellite cell counts following reinnervation when administered as recombinant FST DNA via viral vectors ...
Mark A. Feger, Jonathan Isaacs, Satya Mallu, Dorne Yager, Mary Shall, Gaurangkumar Patel, Omar Protzuk, Akhil S. Bokkisam   +7 more
doaj   +1 more source

Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Recreational use of anabolic-androgenic steroids (AAS) is a public health concern world-wide associated with a range of physical and psychological side effects. Still, people who use AAS tend to be reluctant to seek treatment.
Hans Christian Bordado Henriksen, Ingrid Amalia Havnes, Marie Lindvik Jørstad, Astrid Bjørnebekk   +3 more
doaj   +1 more source

Evaluation of Growth Performance, Efficiency of Dietary Net Energy Utilization, and Carcass Trait Responses of Heavy Finishing Lambs Administered 12 mg of Zeranol Subcutaneously in the Ear 59 d before Harvest

Ruminants, 2023
The objective of this research was to determine the influence of implanting heavy wether lambs with 12 mg of zeranol (1 pellet Ralgro, Merck Animal Health. Madison, NJ, USA) 59 d before harvest.
Emily R. Nold, Thomas C. Norman, Warren C. Rusche, Rosemarie A. Nold, Zachary K. Smith   +4 more
doaj   +1 more source

Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters

Brain and Behavior, 2023
Introduction Prior research has demonstrated that personality disorders and clinical psychiatric syndromes are common among users of anabolic–androgenic steroids (AAS). However, the prevalence, expression, and severity of psychopathology differ among AAS
Marie Lindvik Jørstad, Morgan Scarth, Svenn Torgersen, Harrison Graham Pope, Astrid Bjørnebekk   +4 more
doaj   +1 more source

Sleep Quality After Intradialytic Oral Nutrition: A New Benefit of This Anabolic Strategy? A Pilot Study

Frontiers in Nutrition, 2022
BackgroundSince disturbances of appetite and sleep are closely related and both affect metabolic disorders, it would be expected that a renal specific oral nutritional supplement (RS-ONS) that covers the energy the patient does not consume on the HD day,
Ailema González-Ortiz, Samuel Ramos-Acevedo, Victoria Santiago-Ayala, Victoria Santiago-Ayala, Gabriela Gaytan, Matilde Valencia-Flores, Matilde Valencia-Flores, Ricardo Correa-Rotter, Juan Jesus Carrero, Hong Xu, Ángeles Espinosa-Cuevas, Ángeles Espinosa-Cuevas   +11 more
doaj   +1 more source

Effects of Cycling Intensity on Acute Signaling Adaptations to 8-weeks Concurrent Training in Trained Cyclists

Frontiers in Physiology, 2022
This study examined whether the intensity of endurance stimuli modifies the adaptation in strength and endurance following concurrent training and whether the acute molecular response to concurrent exercise is affected by training status.
T. W. Jones, L. Eddens, J. Kupusarevic, D. C. M. Simoes, M. J. W. Furber, K. A. Van Someren, G. Howatson, G. Howatson   +7 more
doaj   +1 more source

Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO)

Archives of Endocrinology and Metabolism, 2022
Several drugs are available for the treatment of osteoporosis in postmenopausal women. Over the last decades, most patients requiring pharmacological intervention were offered antiresorptive drugs as first-line therapy, while anabolic agents were ...
Barbara C. Silva, Miguel Madeira, Catarina Brasil d’Alva, Sergio Setsuo Maeda, Narriane Chaves Pereira de Holanda, Monique Nakayama Ohe, Vera Szejnfeld, Cristiano A. F. Zerbini, Francisco José Albuquerque de Paula, Francisco Bandeira   +9 more
doaj   +1 more source

Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise

Frontiers in Endocrinology, 2020
Hormones are largely responsible for the integrated communication of several physiological systems responsible for modulating cellular growth and development.
William J. Kraemer, Nicholas A. Ratamess, Wesley C. Hymer, Bradley C. Nindl, Maren S. Fragala   +4 more
doaj   +1 more source

The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence

Archives of Endocrinology and Metabolism, 2022
It is now well recognized that over the lifetime of a patient with osteoporosis, more than one medication will be needed to treat the disease and to decrease fracture risk.
Manju Chandran
doaj   +1 more source